Previous study has demonstrated that in vitro AMPK activation is a key mediator of the changes in substrate utilization during cardiac ischemia and functions to maintain energy homeostasis, cardiac function and myocardial viability [10]. The gene discussed is PRKAA1; the disease is myocardial ischemia.